Safety and Efficacy of Sufentanil Administration by Paramedics in Acute Trauma in Prehospital Setting: Observational Study

What this Trial Is About

Researchers are evaluating the safety and effectiveness of paramedics administering sufentanil intravenously to adults with acute trauma pain, either after consulting an emergency medical doctor by phone or based on their own competency without consultation. This observational study focuses on pain management in trauma patients and aims to build on previous data collected during the COVID-19 pandemic, which may have affected patient cases. The study compares two approaches to sufentanil administration: one where paramedics give the drug after a phone consultation with a medical doctor, and another where paramedics administer it independently based on their training and skills. The study observes patients during prehospital care, assessing outcomes up to 60 minutes after sufentanil is given, including safety and pain relief measures. Participants receive sufentanil from paramedics during emergency response to trauma. Researchers monitor safety by tracking incidents such as apnea, slow breathing, nausea, and vomiting, as well as effectiveness through pain rating scales before administration and at hospital handover. Additional data collected include drug dosage, use of other analgesics, vital signs, oxygen use, and medication needs. The study takes place from July 2024 through March 2025.

Safety and Efficacy of Sufentanil Administration by Paramedics in Acute Trauma